A review article published on July 1, 2015, titled Non-Pharmacological Cognitive Enhancers — Current Perspectives, covers the following categories:
- Physical Exercise
- Meditation and Yoga
- Cognitive Training
- Brain Stimulation
- Computer Based Interventions
And while this article is still rooted in a mainstream medical paradigm we do appreciate its willingness to explore non-drug methods and bring attention to areas like meditation, yoga, spirituality, and yoga, that are usually not considered.
Dr. Richard Horton, known and respected for his role as editor of the esteemed medical journal The Lancet, has stated:
“Much of the scientific literature, perhaps half, may simply be untrue. Afflicted by studies with small sample sizes, tiny effects, invalid exploratory analyses, and flagrant conflicts of interest, together with an obsession for pursuing fashionable trends of dubious importance, science has taken a turn towards darkness.”
In the follow study:
Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled study [PDF file of study]
Researchers utilized just 2000IU a day of Vitamin D for 3 months and found reduced inflammation and reduced intestinal permeability, once again pointing to the importance of Vitamin D.
Visit out Vitamin D Discussion thread to discuss this study or Vitamin D further.
Like many health conditions that do not present in obvious ways to the current diagnostic technology of Western medicine, chronic fatigue syndrome (CFS) has been a marginalized. It is often seen as psychogenic or “not having a medical cause”.
Traditional health practitioners often focus on enhancing digestion and resorting general health of people with CFS symptoms. It can be hard to determine what is the root cause of a person’s problems if their digestion is weak and their diet and lifestyle are not optimal.
Rituximab, a drug which effects cells the make antibodies, was used to treat lymphoma and rheumatoid arthritis. But it was also noticed to benefit CFS symptoms. In a recently published study researchers from Norway put this drug to the test for CFS and found it helped participants significantly.
From the findings of the study:
Major or moderate responses, predefined as lasting improvements in self-reported Fatigue score, were detected in 18 out of 29 patients (intention to treat). Clinically significant responses were seen in 18 out of 28 patients (64%) receiving rituximab maintenance treatment. For these 18 patients, the mean response durations within the 156 weeks study period were 105 weeks in 14 major responders, and 69 weeks in four moderate responders. At end of follow-up (36 months), 11 out of 18 responding patients were still in ongoing clinical remission.
“Chronic Fatigue Syndrome usually responds, slowly, to continued use of Restorative Herbs backed up by short bursts of Immune System stimulants, plus lots of loving attention.” — Christopher Hedley